Evidence for endogenous retroviruses in human chemokine receptor gene introns: possible evolutionary inferences and biological roles

References

• Ahuja, S.K., Murphy, P.M. Molecular piracy of mammalian interleukin-8 receptor type B by herpesvirus saimiri. J. Biol. Chem. 1993, 268, 20691–20694.
   PubMed Web of Science ®Google Scholar
• Murphy, P.M. Molecular piracy of chemokine receptors by herpesviruses. Infect. Agents Dis. 1994, 3, 137–154.
   PubMedGoogle Scholar
• Ahuja, S.K., Gao, J.L., Murphy, P.M. Chemokine receptors and molecular mimicry. Immunol. Today 1994, 15, 281–287.
   Google Scholar
• Wells, T.N., Schwartz, T.W. Plagiarism of the host immune system: lessons about chemokine immunology from viruses. Curr. Opin. Biotechnol. 1997, 8, 741–748.
   PubMed Web of Science ®Google Scholar
• Howard, J., Justus, D.E., Totmenin, A.V., Shchelkunov, S., Kotwal, G.J. Molecular mimicry of the inflammation modulatory proteins (IMPs) of poxviruses: evasion of the inflammatory response to preserve viral habitat. J. Leukoc. Biol. 1998, 64, 68–71.
   PubMed Web of Science ®Google Scholar
• Lalani, A.S., McFadden, G. Evasion and exploitation of chemokines by viruses. Cytokine Growth Factor Rev. 1999, 10, 219–233.
   PubMed Web of Science ®Google Scholar
• Kotwal, G.J. Poxviral mimicry of complement and chemokine system components: what’s the end game? Immunol. Today 2000, 21, 242–248.
   Google Scholar
• Murphy, P.M. Viral exploitation and subversion of the immune system through chemokine mimicry. Nat. Immunol. 2001, 2, 116–122.
   PubMed Web of Science ®Google Scholar
• Alcami, A. Viral mimicry of cytokines, chemokines and their receptors. Nat. Rev. Immunol. 2003, 3, 36–50.
   PubMed Web of Science ®Google Scholar
• Liston, A., McColl, S. Subversion of the chemokine world by microbial pathogens. Bioessays 2003, 25, 478–488.
   PubMed Web of Science ®Google Scholar
• Holst, P.J., Rosenkilde, M.M. Microbiological exploitation of the chemokine system. Microbes Infect. 2003, 5, 179–187.
   PubMed Web of Science ®Google Scholar
• Panaro, M.A., Acquafredda, A., Sisto, M., Lisi, S., Saccia, M., Mitolo, V. Evolution of a “conserved” amino acid sequence: a model study of an in silico investigation of the phylogenesis of some immune receptors. Curr. Pharm. Des. 2006, 12, 4091–4121.
   PubMed Web of Science ®Google Scholar
• Sharp, E.L., Farrell, H.E., Borchers, K., Holmes, E.C., Davis-Poynter, N.J. Sequence analysis of the equid herpesvirus 2 chemokine receptor homologues E1, ORF74 and E6 demonstrates high sequence divergence between field isolates. J. Gen. Virol. 2007, 88, 2450–2462.
   PubMed Web of Science ®Google Scholar
• Beisser, P.S., Lavreysen, H., Bruggeman, C.A., Vink, C. Chemokines and chemokine receptors encoded by cytomegaloviruses. Curr. Top. Microbiol. Immunol. 2008, 325, 221–242.
   PubMed Web of Science ®Google Scholar
• Panaro, M.A., Calvello, R., Lisi, S., Saccia, M., Cianciulli, A., Cavallo, P. Chemokine receptor-related viral protein products. Immunopharmacol. Immunotoxicol. 2010, 32, 17–27.
   PubMed Web of Science ®Google Scholar
• Rosenkilde, M.M., Waldhoer, M., Lüttichau, H.R., Schwartz, T.W. Virally encoded 7TM receptors. Oncogene 2001, 20, 1582–1593.
   PubMedGoogle Scholar
• Holst, P.J., Lüttichau, H.R., Schwartz, T.W., Rosenkilde, M.M. Virally encoded chemokines and chemokine receptors in the role of viral infections. Contrib. Microbiol. 2003, 10, 232–252.
   PubMedGoogle Scholar
• Rosenkilde, M.M. Virus-encoded chemokine receptors–putative novel antiviral drug targets. Neuropharmacology 2005, 48, 1–13.
   PubMedGoogle Scholar
• Ikeda, T., Shibata, J., Yoshimura, K., Koito, A., Matsushita, S. Recurrent HIV-1 integration at the BACH2 locus in resting CD4+ T cell populations during effective highly active antiretroviral therapy. J. Infect. Dis. 2007, 195, 716–725.
   PubMed Web of Science ®Google Scholar
• Chang, C.M., Coville, J.L., Coquerelle, G., Gourichon, D., Oulmouden, A., Tixier-Boichard, M. Complete association between a retroviral insertion in the tyrosinase gene and the recessive white mutation in chickens. BMC Genomics. 2006, 5, 7–19.
   Google Scholar
• Chang, C.M., Furet, J.P., Coville, J.L., Coquerelle, G., Gourichon, D., Tixier-Boichard, M. Quantitative effects of an intronic retroviral insertion on the transcription of the tyrosinase gene in recessive white chickens. Anim. Genet. 2007, 38, 162–167.
   PubMed Web of Science ®Google Scholar
• Tsukahara, T., Agawa, H., Matsumoto, S., Matsuda, M., Ueno, S., Yamashita, Y., Yamada, K., Tanaka, N., Kojima, K., Takeshita, T. Murine leukemia virus vector integration favors promoter regions and regional hot spots in a human T-cell line. Biochem. Biophys. Res. Commun. 2006, 345, 1099–1107.
   PubMed Web of Science ®Google Scholar
• Mack, K.D., Jin, X., Yu, S., Wei, R., Kapp, L., Green, C., Herndier, B., Abbey, N.W., Elbaggari, A., Liu, Y., McGrath, M.S. HIV insertions within and proximal to host cell genes are a common finding in tissues containing high levels of HIV DNA and macrophage-associated p24 antigen expression. J. Acquir. Immune Defic. Syndr. 2003, 33, 308–320.
   PubMed Web of Science ®Google Scholar
• Panaro, M.A., Calvello, R., Lisi, S., Saccia, M., Mitolo, C.I., Cianciulli, A. Viral sequence integration into introns of chemokine receptor genes. Immunopharmacol. Immunotoxicol. 2009, 31, 589–594.
   PubMed Web of Science ®Google Scholar
• Daniel, R., Smith, J.A. Integration site selection by retroviral vectors: molecular mechanism and clinical consequences. Hum. Gene Ther. 2008, 19, 557–568.
   PubMed Web of Science ®Google Scholar
• Schaffer, D.V., Koerber, J.T., Lim, K.I. Molecular engineering of viral gene delivery vehicles. Annu. Rev. Biomed. Eng. 2008, 10, 169–194.
   PubMed Web of Science ®Google Scholar
• Nienhuis, A.W. Development of gene therapy for blood disorders. Blood 2008, 111, 4431–4444.
   PubMed Web of Science ®Google Scholar
• Bauzon, M., Hermiston, T.W. Exploiting diversity: genetic approaches to creating highly potent and efficacious oncolytic viruses. Curr. Opin. Mol. Ther. 2008, 10, 350–355.
   PubMedGoogle Scholar
• Harrington, K.J., Melcher, A., Vassaux, G., Pandha, H.S., Vile, R.G. Exploiting synergies between radiation and oncolytic viruses. Curr. Opin. Mol. Ther. 2008, 10, 362–370.
   PubMed Web of Science ®Google Scholar
• Guo, Z.S., Thorne, S.H., Bartlett, D.L. Oncolytic virotherapy: molecular targets in tumor-selective replication and carrier cell-mediated delivery of oncolytic viruses. Biochim. Biophys. Acta 2008, 1785, 217–231.
   PubMed Web of Science ®Google Scholar
• Hacein-Bey-Abina, S., Von Kalle, C., Schmidt, M., McCormack, M.P., Wulffraat, N., Leboulch, P., Lim, A., Osborne, C.S., Pawliuk, R., Morillon, E., Sorensen, R., Forster, A., Fraser, P., Cohen, J.I., de Saint Basile, G., Alexander, I., Wintergerst, U., Frebourg, T., Aurias, A., Stoppa-Lyonnet, D., Romana, S., Radford-Weiss, I., Gross, F., Valensi, F., Delabesse, E., Macintyre, E., Sigaux, F., Soulier, J., Leiva, L.E., Wissler, M., Prinz, C., Rabbitts, T.H., Le Deist, F., Fischer, A., Cavazzana-Calvo, M. LMO2-associated clonal T cell proliferation in two patients after gene therapy for SCID-X1. Science 2003, 302, 415–419.
   PubMed Web of Science ®Google Scholar
• Hacein-Bey-Abina, S., Garrigue, A., Wang, G.P., Soulier, J., Lim, A., Morillon, E., Clappier, E., Caccavelli, L., Delabesse, E., Beldjord, K., Asnafi, V., MacIntyre, E., Dal Cortivo, L., Radford, I., Brousse, N., Sigaux, F., Moshous, D., Hauer, J., Borkhardt, A., Belohradsky, B.H., Wintergerst, U., Velez, M.C., Leiva, L., Sorensen, R., Wulffraat, N., Blanche, S., Bushman, F.D., Fischer, A., Cavazzana-Calvo, M. Insertional oncogenesis in 4 patients after retrovirus-mediated gene therapy of SCID-X1. J. Clin. Invest. 2008, 118, 3132–3142.
   PubMed Web of Science ®Google Scholar
• Baum, C., Düllmann, J., Li, Z., Fehse, B., Meyer, J., Williams, D.A., von Kalle, C. Side effects of retroviral gene transfer into hematopoietic stem cells. Blood 2003, 101, 2099–2114.
   PubMed Web of Science ®Google Scholar
• Themis, M., May, D., Coutelle, C., Newbold, R.F. Mutational effects of retrovirus insertion on the genome of V79 cells by an attenuated retrovirus vector: implications for gene therapy. Gene Ther. 2003, 10, 1703–1711.
   PubMedGoogle Scholar
• Laufs, S., Nagy, K.Z., Giordano, F.A., Hotz-Wagenblatt, A., Zeller, W.J., Fruehauf, S. Insertion of retroviral vectors in NOD/SCID repopulating human peripheral blood progenitor cells occurs preferentially in the vicinity of transcription start regions and in introns. Mol. Ther. 2004, 10, 874–881.
   PubMed Web of Science ®Google Scholar
• Kustikova, O., Fehse, B., Modlich, U., Yang, M., Düllmann, J., Kamino, K., von Neuhoff, N., Schlegelberger, B., Li, Z., Baum, C. Clonal dominance of hematopoietic stem cells triggered by retroviral gene marking. Science 2005, 308, 1171–1174.
   PubMed Web of Science ®Google Scholar
• Du, Y., Jenkins, N.A., Copeland, N.G. Insertional mutagenesis identifies genes that promote the immortalization of primary bone marrow progenitor cells. Blood 2005, 106, 3932–3939.
   PubMed Web of Science ®Google Scholar
• Perincheri, S., Dingle, R.W., Peterson, M.L., Spear, B.T. Hereditary persistence of alpha-fetoprotein and H19 expression in liver of BALB/cJ mice is due to a retrovirus insertion in the Zhx2 gene. Proc. Natl. Acad. Sci. U.S.A. 2005, 102, 396–401.
   PubMedGoogle Scholar
• Nienhuis, A.W., Dunbar, C.E., Sorrentino, B.P. Genotoxicity of retroviral integration in hematopoietic cells. Mol. Ther. 2006, 13, 1031–1049.
   PubMed Web of Science ®Google Scholar
• Nienhuis, A.W. Assays to evaluate the genotoxicity of retroviral vectors. Mol. Ther. 2006, 14, 459–460.
   PubMedGoogle Scholar
• Larsson, E., Andersson, G. Beneficial role of human endogenous retroviruses: facts and hypotheses. Scand. J. Immunol. 1998, 48, 329–338.
   PubMedGoogle Scholar
• Sverdlov, E.D. Perpetually mobile footprints of ancient infections in human genome. FEBS Lett. 1998, 428, 1–6.
   PubMed Web of Science ®Google Scholar
• Khodosevich, K., Lebedev, Y., Sverdlov, E. Endogenous retroviruses and human evolution. Comp. Funct. Genomics 2002, 3, 494–498.
   PubMedGoogle Scholar
• Nelson, P.N., Carnegie, P.R., Martin, J., Davari Ejtehadi, H., Hooley, P., Roden, D., Rowland-Jones, S., Warren, P., Astley, J., Murray, P.G. Demystified. Human endogenous retroviruses. MP, Mol. Pathol. 2003, 56, 11–18.
   PubMedGoogle Scholar
• de Parseval, N., Heidmann, T. Human endogenous retroviruses: from infectious elements to human genes. Cytogenet. Genome Res. 2005, 110, 318–332.
   PubMed Web of Science ®Google Scholar
• Medstrand, P., Mager, D.L., Yin, H., Dietrich, U., Blomberg, J. Structure and genomic organization of a novel human endogenous retrovirus family: HERV-K (HML-6). J. Gen. Virol. 1997, 78 (Pt 7), 1731–1744.
   PubMedGoogle Scholar
• Andersson, A.C., Svensson, A.C., Rolny, C., Andersson, G., Larsson, E. Expression of human endogenous retrovirus ERV3 (HERV-R) mRNA in normal and neoplastic tissues. Int. J. Oncol. 1998, 12, 309–313.
   PubMedGoogle Scholar
• Tönjes, R.R., Czauderna, F., Kurth, R. Genome-wide screening, cloning, chromosomal assignment, and expression of full-length human endogenous retrovirus type K. J. Virol. 1999, 73, 9187–9195.
   PubMed Web of Science ®Google Scholar
• Corpet, F. Multiple sequence alignment with hierarchical clustering. Nucleic Acids Res. 1988, 16, 10881–10890.
   PubMed Web of Science ®Google Scholar
• Widegren, B., Kjellman, C., Aminoff, S., Sahlford, L.G., Sjögren, H.O. The structure and phylogeny of a new family of human endogenous retroviruses. J. Gen. Virol. 1996, 77 (Pt 8), 1631–1641.
   PubMedGoogle Scholar
• Seifarth, W., Baust, C., Schön, U., Reichert, A., Hehlmann, R., Leib-Mösch, C. HERV-IP-T47D, a novel type C-related human endogenous retroviral sequence derived from T47D particles. AIDS Res. Hum. Retroviruses 2000, 16, 471–480.
   PubMedGoogle Scholar
• Seifarth, W., Skladny, H., Krieg-Schneider, F., Reichert, A., Hehlmann, R., Leib-Mösch, C. Retrovirus-like particles released from the human breast cancer cell line T47-D display type B- and C-related endogenous retroviral sequences. J. Virol. 1995, 69, 6408–6416.
   PubMed Web of Science ®Google Scholar
• de Parseval, N., Casella, J., Gressin, L., Heidmann, T. Characterization of the three HERV-H proviruses with an open envelope reading frame encompassing the immunosuppressive domain and evolutionary history in primates. Virology 2001, 279, 558–569.
   PubMedGoogle Scholar